Back to Journals » Degenerative Neurological and Neuromuscular Disease » Volume 2

Review

Evaluation of tafamidis as first-line therapeutic agent for transthyretin familial amyloidotic polyneuropathy

       
Total article views   HTML views PDF downloads Totals
7,830 Dovepress* 7,830+ 2,643 10,473
Totals 7,830 2,643 10,473
*Since 23 October 2012
+Since July 2016

View citations on Google Scholar